Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-05

Clinical Trial Update: Comparison of the Efficacy and the Safety of Different Schedules of Administration of Sub-lingual Immunotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing different schedules of sublingual immunotherapy for pollen allergy has completed, evaluating efficacy and safety of the administration r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sub-lingual immunotherapy

Snippet

Sponsor: ASST Fatebenefratelli Sacco | Conditions: Pollen Allergy | Phase 3 | Status: COMPLETED